Language
Search
News
- Bruker Introduces Novel Fourier 300, a Compact, Easy-to-Use 300 MHz NMR
- Bruker Corporation Reports Record Financial Results for the Fourth Quarter and Full Year 2009
- Bruker Announces Over 100 Systems Orders Received in the Second Half of 2009 from Global Stimulus...
- Bruker Announces Framework Agreement for EPR e-scan™ Beer Analyzers to Enable New Levels of Quality...
- World’s First 1000 MHz NMR Spectrometer Now Offers New Research Capabilities to European...
Upcoming Events
Dose-Effect
Brain Infarct: Dose-Effect Relation of a New Compound
Courtesy of D. Stiller
Boehringer Ingelheim Pharma, Germany
- These data were acquired using a BioSpec 47/40
The size of a lesion in the rat brain is reduced after treatment with a new cerebroprotective drug. Lesion appears bright in the T2W-RARE images.
A: Control
B: 3 mg dose
C: 10 mg dose
D: 30 mg dose